PDE7A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.250200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.033200E-01
Normal-vs-Stage2
2.326600E-01
Normal-vs-Stage3
1.838580E-01
Normal-vs-Stage4
1.880380E-01
Stage1-vs-Stage2
3.365000E-01
Stage1-vs-Stage3
3.486000E-01
Stage1-vs-Stage4
5.562000E-01
Stage2-vs-Stage3
5.89861492983346E-13
Stage2-vs-Stage4
1.097660E-02
Stage3-vs-Stage4
6.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.269600E-01
Normal-vs-AfricanAmerican
2.292000E-01
Normal-vs-Asian
2.045400E-01
Caucasian-vs-AfricanAmerican
9.777200E-01
Caucasian-vs-Asian
1.335840E-01
AfricanAmerican-vs-Asian
2.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.187000E-01
Normal-vs-Female
2.335400E-01
Male-vs-Female
2.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.508000E-01
Normal-vs-Age(41-60Yrs)
2.380000E-01
Normal-vs-Age(61-80Yrs)
2.201200E-01
Normal-vs-Age(81-100Yrs)
2.199200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.628600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.317800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.617600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.929850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.412400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.382800E-01
Normal-vs-Daily Drinker
2.086800E-01
Normal-vs-Weekly Drinker
2.036000E-01
Normal-vs-Occasional Drinker
2.057400E-01
Normal-vs-Social Drinker
2.601200E-01
Non Drinker-vs-Daily Drinker
1.855370E-01
Non Drinker-vs-Weekly Drinker
9.242400E-02
Non Drinker-vs-Occasional Drinker
1.198590E-01
Non Drinker-vs-Social Drinker
5.841800E-01
Daily Drinker-vs-Weekly Drinker
7.709600E-01
Daily Drinker-vs-Occasional Drinker
8.616200E-01
Daily Drinker-vs-Social Drinker
1.550570E-01
Weekly Drinker-vs-Occasional Drinker
8.956200E-01
Weekly Drinker-vs-Social Drinker
1.103800E-01
Occasional Drinker-vs-Social Drinker
1.275610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.312800E-01
Normal-vs-Grade 2
1.315000E-01
Normal-vs-Grade 3
1.306400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.720000E-01
Grade 1-vs-Grade 3
5.620200E-01
Grade 1-vs-Grade 4
4.312800E-01
Grade 2-vs-Grade 3
2.128000E-01
Grade 2-vs-Grade 4
1.315000E-01
Grade 3-vs-Grade 4
1.306400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.352200E-01
Normal-vs-NonDiabetic
2.188000E-01
Diabetic-vs-NonDiabetic
3.425400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.322800E-01
Normal-vs-NoPancreatitis
2.225400E-01
Pancreatitis-vs-NoPancreatitis
8.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.182200E-01
Normal-vs-N1
2.309200E-01
N0-vs-N1
3.827600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.109800E-01
Normal-vs-TP53-NonMutant
2.452000E-01
TP53-Mutant-vs-TP53-NonMutant
6.305500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
